Call Us: 561-689-0606
Info@PalmBeachResearch.com

News

The latest from the Industry and PBRC.

What “Unboiling” An Egg Can Mean For Cancer Drug Development

In a strange and exciting twist, researchers from the University of California, Irvine (UCI) and Flinders University announced this week they have discovered a new way to “unboil” a hen’s egg — a task that could have huge ramifications for the biotech industry as it races to get...
READ MORE

December 15, 2014 – Collegium Pharmaceutical Submits New Drug Application for Xtampza™ ER (oxycodone extended-release); Its Abuse-Deterrent, Extended-Release Analgesic for the Treatment of Chronic Pain

POSTED IN PRESS RELEASES Contact: Doug Carlson Vice President, Corporate Development Collegium Pharmaceutical, Inc. 781-713-3739 dcarlson@collegiumpharma.com Collegium Pharmaceutical Submits New Drug Application for Xtampza™ ER (oxycodone extended-release); Its Abuse-Deterrent,...
READ MORE

Knee Osteoarthritis: Acetaminophen Least Effective Choice

by Ricki Lewis, PhD, Medscape Medical News Despite the prevalence of knee osteoarthritis (OA), few studies compare treatments head-to-head. Now, a network meta-analysis compares 137 reports on the effectiveness of such treatments and reveals that acetaminophen, the most widely...
READ MORE

Synergy Pharmaceuticals Announces Positive Results of SP-333 Phase 2 Trial in Patients with Opioid-Induced Constipation

NEW YORK– Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced positive top-line results from a phase 2 trial assessing safety, efficacy and dose-response of three different once-daily oral SP-333 tablets (1.0, 3.0 and 6.0 mg) compared with placebo in 289 patients...
READ MORE

Sleep off addicton to cigarettes?

Olfactory aversive conditioning during sleep may teach cigarette smokers to dislike cigarettes and help them cut back, a new study hints. Smokers who were exposed to the smell of cigarettes along with a profoundly unpleasant odor during a single night of sleep reduced their...
READ MORE